![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The daily Top 10 COVID papers |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in
Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
Acta Haematol. 2020;143:567-573.
PubMed
Abstract available
Single-Antibody Evaluation of T-Cell Receptor beta Constant Chain Monotypia by
Flow Cytometry Facilitates the Diagnosis of T-Cell Large Granular Lymphocytic
Leukemia.
Am J Clin Pathol. 2021 Jan 13. pii: 6092418. doi: 10.1093.
PubMed
Abstract available
Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid
leukemia after allogeneic hematopoietic cell transplantation. A retrospective
multicenter trial.
Ann Hematol. 2021 Jan 13. pii: 10.1007/s00277-021-04398.
PubMed
Abstract available
Intracranial hemorrhage as presentation of chronic lymphocytic leukemia
successfully treated with ibrutinib.
Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04393.
PubMed
Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy
cell leukemia variant.
Ann Hematol. 2021 Jan 12. pii: 10.1007/s00277-021-04408.
PubMed
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness
patient.
Ann Hematol. 2021 Jan 12. pii: 10.1007/s00277-021-04403.
PubMed
Venetoclax-induced panniculitis in an acute myeloid leukemia patient.
Ann Hematol. 2021 Jan 13. pii: 10.1007/s00277-020-04372.
PubMed
HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient.
Ann Hematol. 2021 Jan 14. pii: 10.1007/s00277-021-04409.
PubMed
Reduced intensity of early intensification does not increase the risk of relapse
in children with standard risk acute lymphoblastic leukemia - a multi-centric
clinical study of GD-2008-ALL protocol.
BMC Cancer. 2021;21:59.
PubMed
Abstract available
The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation
syndrome in acute promyelocytic leukemia.
BMC Cancer. 2021;21:46.
PubMed
Abstract available
Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of
acute myeloid leukaemia cells.
Br J Haematol. 2020;189:694-706.
PubMed
Abstract available
BCR-ABL1-positive acute myeloid leukaemia relapsing as acute lymphoblastic
leukaemia.
Br J Haematol. 2020;189:591.
PubMed
Good news for acute myeloid leukaemia patients from the stroll niche?
Br J Haematol. 2020;189:597-599.
PubMed
Five-year survival follow-up of a phase III randomised trial comparing ofatumumab
versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic
leukaemia: a short report.
Br J Haematol. 2020;189:689-693.
PubMed
Abstract available
Outcome of children relapsing after first allogeneic haematopoietic stem cell
transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of
333 children.
Br J Haematol. 2020;189:745-750.
PubMed
Abstract available
Improving the prediction of acute myeloid leukaemia outcomes by complementing
mutational profiling with ex vivo chemosensitivity.
Br J Haematol. 2020;189:672-683.
PubMed
Abstract available
Identification of relapse-associated gene mutations by next-generation sequencing
in low-risk acute myeloid leukaemia patients.
Br J Haematol. 2020;189:718-730.
PubMed
Abstract available
How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy.
Br J Haematol. 2020;189:625-634.
PubMed
Abstract available
Test trial of spike-in immunoglobulin heavy-chain (IGH) controls for next
generation sequencing quantification of minimal residual disease in acute
lymphoblastic leukaemia.
Br J Haematol. 2020;189:e150-e154.
PubMed
Incidence of hip and knee osteonecrosis and their associations with bone mineral
density in children with acute lymphoblastic leukaemia.
Br J Haematol. 2020;189:e177-e181.
PubMed
Gains of EPOR and ERG genes in adult erythroleukaemia.
Br J Haematol. 2020;189:e174-e177.
PubMed
Mast cell sarcoma with concurrent mast cell leukaemia.
Br J Haematol. 2020;189:e160-e164.
PubMed
Posttransplantation cyclophosphamide improves transplantation outcomes in
patients with AML/MDS who are treated with checkpoint inhibitors.
Cancer. 2020;126:2193-2205.
PubMed
Abstract available
Phase 2 study of lenalidomide maintenance for patients with high-risk acute
myeloid leukemia in remission.
Cancer. 2021 Jan 15. doi: 10.1002/cncr.33409.
PubMed
Abstract available
Mathematical Modeling Provides Evidence for Niche Competition in Human AML and
Serves as a Tool to Improve Risk Stratification.
Cancer Res. 2020;80:3983-3992.
PubMed
Abstract available
Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote
Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
Cancer Res. 2020;80:3663-3676.
PubMed
Abstract available
Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular
and biologic features and impact on survival.
Eur J Haematol. 2021 Jan 12. doi: 10.1111/ejh.13577.
PubMed
Abstract available
Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of
EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
Exp Cell Res. 2021 Jan 8:112469. doi: 10.1016/j.yexcr.2020.112469.
PubMed
Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or
B-2-like based on a minimal transcriptional signature.
Exp Hematol. 2020;90:65-71.
PubMed
Abstract available
Clinical and genomic characterization of patients diagnosed with the provisional
entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Genes Chromosomes Cancer. 2021 Jan 12. doi: 10.1002/gcc.22936.
PubMed
Abstract available
Allogeneic hematopoietic stem cell transplantation for adult T-cell
leukemia/lymphoma with HTLV-1-associated myelopathy.
Int J Hematol. 2021 Jan 10. pii: 10.1007/s12185-020-03075.
PubMed
Abstract available
Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy.
J Clin Oncol. 2021 Jan 12:JCO2000475. doi: 10.1200/JCO.20.00475.
PubMed
Graft Versus Leukemia: Current Status and Future Perspectives.
J Clin Oncol. 2021 Jan 12:JCO2001801. doi: 10.1200/JCO.20.01801.
PubMed
Abstract available
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected
Bispecific Antibodies.
J Clin Oncol. 2021 Jan 12:JCO2001564. doi: 10.1200/JCO.20.01564.
PubMed
Nelarabine in Pediatric and Young Adult T-Cell Acute Lymphoblastic
Leukemia-Clearly Beneficial?
J Clin Oncol. 2021 Jan 14:JCO2002973. doi: 10.1200/JCO.20.02973.
PubMed
Precursor B-Cell Acute Lymphoblastic Leukemia With MYC and BCL2 Rearrangements
Presenting as Extensive Extranodal Disease in an Adolescent.
J Pediatr Hematol Oncol. 2021 Jan 11. pii: 00043426-900000000-97026.
PubMed
Abstract available
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for
the treatment of chronic lymphocytic leukemia.
Leuk Lymphoma. 2021 Jan 11:1-18. doi: 10.1080/10428194.2020.1864352.
PubMed
Abstract available
Arsenic trioxide and all-trans retinoic acid in the treatment of children with
newly diagnosed acute promyelocytic leukemia.
Leuk Lymphoma. 2021 Jan 13:1-6. doi: 10.1080/10428194.2020.1856832.
PubMed
Azacitidine and venetoclax for the treatment of accelerated and blast phase
myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series.
Leuk Lymphoma. 2021 Jan 15:1-6. doi: 10.1080/10428194.2020.1869961.
PubMed
SARS-CoV-2 antibody responses in patients with acute leukaemia.
Leukemia. 2021;35:289-292.
PubMed
PTPN11 mutations are associated with poor outcomes across myeloid malignancies.
Leukemia. 2021;35:286-288.
PubMed
Activating somatic and germline TERT promoter variants in myeloid malignancies.
Leukemia. 2021;35:274-278.
PubMed
Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for
their immunosuppressive function.
Leukemia. 2021;35:107-118.
PubMed
Abstract available
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant
cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in
murine models.
PLoS One. 2021;16:e0245232.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by